Morning Movers 11/06: ACLS, CVM, ZIOP, LPSN, CABL, ZGEN Higher; NHWK, GOK, CROX, CVI, RAIL, CSTR Lower
NightHawk Radiology Holdings, Inc. (NASDAQ: NHWK) 26% LOWER; reports Q3 EPS of $0.17, ex-items, 1 cent better than the analyst estimate of $0.16. Revenue for the quarter was $43.5 million, which compares to the estimate of $42.71 million. Sees Q4 adj-EPS of $0.08-$0.10, versus the consensus of $0.15, on sales of $38-$40 million, versus the consensus of $40.13 million.
Geokinetics Inc. (AMEX: GOK) 22.1% LOWER; reports Q3 loss of $0.41, cents better than the analyst estimate of ($0.08). Revenue for the quarter was $96.80 million, which compares to the estimate of $133.92 million.
Axcelis Technologies, Inc. (NASDAQ: ACLS) 19.5% HIGHER; reports Q3 loss of $0.15, 2 cents better than the analyst estimate of ($0.17). Revenue for the quarter was $35 million, which compares to the estimate of $31.95 million. Sees Q409 cash Break Even.
Crocs, Inc. (NASDAQ: CROX) 17.8% LOWER; reports Q3 EPS of $0.01, 9 cents better than the analyst estimate of ($0.08). Revenue for the quarter was $177.1 million, which compares to the estimate of $156.41 million. Sees Q4 loss of $0.15-$0.20, versu loss of $0.16. Sees revs of $110-$115 million, versus the consensus of $113.6 million.
CEL-SCI Corporation (NYSE Amex: CVM) 16.5% HIGHER; announced today that an Institutional Review Board of The Johns Hopkins University School of Medicine (Johns Hopkins) has given clearance for the Company's first clinical study to proceed. View the release.
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) 15.6% HIGHER; presented today at the 15th Annual Connective Tissue Oncology Society Meeting, positive interim data from the multicenter randomized Phase II trial of palifosfamide (ZymafosTM, ZIO-201) treating patients with unresectable or metastatic soft tissue sarcoma. More from the release.
CVR Energy, Inc. (NYSE: CVI) 15.6% LOWER; today announced that one of its stockholders has commenced a registered underwritten public offering of 7,376,264 shares of CVR Energy's common stock.
LivePerson (NASDAQ: LPSN) 15.1% HIGHER; reports Q3 EPS of $0.08, 2 cents better than the analyst estimate of $0.06. Revenue for the quarter was $22.3 million, which compares to the estimate of $21.61 million. LivePerson sees Q4 EPS $0.06-$0.07, versus the consensus of $0.06. Sees sales of $23.4-$23.7 million, versus the consensus of $23 million. LivePerson raises FY09 EPS view to $0.26-$0.27, versus the consensus of $0.24.
China Cablecom (Nasdaq: CABL) 15% HIGHER; continuing higher today following yesterday's 26.5% surge and Wednesday's 7% jump.
ZymoGenetics Inc. (NASDAQ: ZGEN) 14.8% HIGHER; reports Q3 loss of $0.17, 3 cents better than the analyst estimate of ($0.20). Revenue for the quarter was $27.5 million, which compares to the estimate of $31.52 million. The stock was also upgraded at Wedbush.
FreightCar America, Inc. (NASDAQ: RAIL) 13.8% LOWER; reports Q2 EPS of $0.09 vs. consensus of $0.22. Revenues were $55.1 million vs. $78.00 million consensus. Click here for the full report.
Coinstar, Inc. (NASDAQ: CSTR) 12.8% LOWER; reports Q3 EPS of $0.31, 6 cents better than the analyst estimate of $0.25. Revenue for the quarter was $296 million, which compares to the estimate of $331.85 million.
Move, Inc. (NASDAQ: MOVE) 12.6% LOWER; reports Q3 EPS of $0.00, versus the analyst estimate of $0.02. Revenue for the quarter was $52.90 million, which compares to the estimate of $54.69 million. Sees Q4 sales $47 - $48 million, versus $54.6 million. Sees FY10 $184 - $192 million, versus $230.7 million
Boston Beer Company (NYSE: SAM) 12.5% HIGHER; reports Q3 adjusted EPS of $0.58, versus the analyst estimate of $0.39. Revenue for the quarter was $108.7 million, which compares to the estimate of $107.46 million.
Arbor Realty Trust (NYSE: ABR) 12.3% LOWER; reports Q3 FFO loss of $1.73, versus the analyst estimate of ($1.33). Revenue for the quarter was $30.80 million, which compares to the estimate of $30.07 million.
General Steel (NYSE: GSI) 12% HIGHER; reported Q3 EPS of $0.22, 12 cents better than the analyst estimate of $0.10. Revenue for the quarter was $484.8 million, which compares to the estimate of $456.06 million.
Glimcher Realty Trust (NYSE: GRT) 11.6% HIGHER; GRT shares are moving higher today following news of a JV with Blackstone (NYSE: BX). Click here for the full report.
Rochester Medical Corporation (NASDAQ: ROCM) 11.6% HIGHER; reports Q4 EPS of $0.01, 1 cents below the analyst estimate of $0.02. Revenue for the quarter was $9.01 million, which compares to the estimate of $9.57 million.
M&F Worldwide Corp. (NYSE: MFW) 11% HIGHER; reports Q3 adjusted EPS of $1.87, cents better than the analyst estimate of $1.02. Revenue for the quarter was $425.70 million, which compares to the estimate of $449.57 million.
Willbros Group (NYSE: WG) 10.7% HIGHER; the stock was upgraded at KeyBanc, Jesup & Lamont and Capital One.
American Reprographics Company (NYSE: ARP) 10.4% HIGHER; reports Q3 EPS of $0.06, 3 cents better than the analyst estimate of $0.03. Revenue for the quarter was $119.4 million, which compares to the estimate of $116.03 million. American Reprographics reaffirms FY09.
Hansen Natural (NASDAQ: HANS) 10.4% LOWER; reports Q3 EPS of $0.60, 3 cents below the analyst estimate of $0.63. Revenue for the quarter was $307.9 million, which compares to the estimate of $309.19 million.
Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) 10.4% LOWER; reports Q3 EPS of $0.37, even with the analyst estimate of $0.37. Revenue for the quarter was $187 million, which compares to the estimate of $197.54 million.
TASER Int'l (Nasdaq: TASR) 10.3% HIGHER; J.P. Morgan upgrades the stock from Neutral to Overweight. Price target lowered to $6.50.
Occam Networks (NASDAQ: OCNW) 10.3% HIGHER; reports Q3 EPS of $0.01, ex-items, 9 cents better than the analyst estimate of ($0.08). Revenue for the quarter was $21.7 million, which compares to the estimate of $22.10 million. Sees Q4 sales unchanged vs. Q3. The stock was upgraded to Buy at Jefferies.
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) 9.9% HIGHER; reports Q3 loss of $0.03, 1 cents better than the analyst estimate of ($0.04). Revenue for the quarter was $7.9 million, which compares to the estimate of $7.08 million. Sees FY09 sales $33 - $34 million, versus $34.30 million consensus.
To get this report daily, visit http://www.streetinsider.com/entities/Morning+Movers.
Create E-mail AlertRelated Categories
Special ReportsStocks Mentioned
+0.02
-0.05Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
